M. Muscaritoli

Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats.

R. Bellantone, M. Muscaritoli, P. Costelli, 2002, Cytokine.

Perspectives of health care professionals on cancer cachexia: results from three global surveys

M. Muscaritoli, A. Molfino, F. Rossi Fanelli, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.

F. Ceci, G. Giunchi, M. Muscaritoli, 1986, Gut.

Amino acids and hepatic encephalopathy

M. Muscaritoli, R. Strom, C. Cangiano, 1987, Progress in Neurobiology.

Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib.

R. Latagliata, M. Muscaritoli, F. Rossi Fanelli, 2007, Leukemia research.

Request for regulatory guidance for cancer cachexia intervention trials

L. Ferrucci, M. Polkey, K. Kalantar-Zadeh, 2015, Journal of cachexia, sarcopenia and muscle.

Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment.

F. Mandelli, M. Muscaritoli, M. Breccia, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.